Key result
Metabolic syndrome features chronic low-grade inflammation and cytokine activity alongside obesity and insulin resistance.
Why the study?
Metabolic syndrome is a growing clinical and public health problem worldwide characterized by inflammatory cytokine activity and chronic low-grade inflammation.
Key points are not available for this paper at this time.
Design
Review
Supports inflammation as a key feature of metabolic syndrome; leaves open whether cytokine modulation improves outcomes.
Metabolic syndrome (MS) is an important clinical and public health problem, especially in Western society, and is affecting more and more people worldwide. Although most cases of MS are considered obese and insulin-resistant, they are characterized by inflammatory cytokine activity and chronic low-grade inflammation.
No takes yet. Share an insight, caveat, or question.
Armutçu et al. (2020) studied this question. Metabolic syndrome is characterized by inflammatory cytokine activity and chronic low-grade inflammation, alongside obesity and insulin resistance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: